Canada's largest open-access rural networks upgraded with advanced routing and switching layers to enhance performance and resilience
SANTA CLARA, Calif., December 10, 2024 – IP Infusion, a global leader in open networking solutions, announced today that solution integrator and managed service operator Dataduct Networks is modernizing Nova Scotia's fiber network with IP Infusion's advanced networking software. This system upgrade, architected in collaboration with open networking provider FONEX, enables integration of hardware from multiple vendors and implementation of sophisticated features for scalability and resiliency.
The upgrade introduces advanced networking capabilities, including Ethernet VPN (EVPN) and Segment Routing MPLS (SR-MPLS). These technologies automate redundancy, ensuring rapid failover during network disruptions and significantly reducing downtime. IP Infusion's software powered the deployment of SR-MPLS, enhancing overall network resilience while reducing operational burdens on Dataduct Networks' engineering teams.
Beyond SR-MPLS, IP Infusion's rich feature set enables Dataduct Networks to optimize and manage the network effectively. Customizable tools support traffic engineering, network slicing, and enhanced security protocols, allowing operators to tailor the system to their specific needs.
"This project demonstrates the importance of selecting the right software to tackle complex networking challenges and secure long-term operational success," said Richard Bourret, CEO of Dataduct Networks. "As a market leader, we found IP Infusion, with FONEX's support, to be the ideal long-term partner for this deployment."
"With IP Infusion and FONEX, Dataduct Networks successfully modernized the county's optical broadband network. The flexibility of open networking solutions proved invaluable for system upgrades like this," said Pasquale Di Pierro, CEO of FONEX. "IP Infusion's domain expertise in open networking operating systems and its performance have proven to be highly competitive in today's networking market."
"Intelligent networking software from IP Infusion transforms the value proposition for network upgrades," said Atsushi Ogata, President and CEO of IP Infusion. "Built on open computing standards, OcNOS guarantees both immediate value and long-term stability."
关于 IP Infusion
IP Infusion develops open network software solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion leads the market in Network Operating Systems. Its flagship platform, OcNOS®, empowers network operators to disaggregate their networks, streamline operations, and reduce total cost of ownership (TCO). Headquartered in Santa Clara, Calif., IP Infusion is a wholly owned subsidiary of ACCESS CO., LTD. For more information, visit www.ipinfusion.com/.
About Dataduct Networks
Dataduct Networks is a leading solution integrator and managed service operator specializing in the design, deployment, and management of cutting-edge communication infrastructure. Committed to bridging the digital divide, Dataduct Networks delivers high-speed internet access to underserved communities and provides mission-critical services for municipalities and utilities. www.dataduct.io
About FONEX
FONEX Data Systems delivers innovative network infrastructure design solutions for service providers. Its carrier-grade portfolio, combined with in-house technical expertise, positions FONEX as a trusted partner for telecom solutions across Canada and Europe. For more information, visit www.fonex.com.
媒体联系
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
关于 IP Infusion
IP Infusion 是开放网络软件的领先供应商，提供面向服务提供商、数据中心和 AI Fabric 网络的电信级网络操作系统 OcNOS。凭借 26+ 年的网络技术积累和全球 600+ 家运营商的部署，IP Infusion 在 Edgecore Networks、UfiSpace 和 Celestica 等合作伙伴经过验证的开放硬件上，实现开放、多厂商、高性价比且灵活的网络基础设施。IP Infusion 是 ACCESS CO., LTD.（东京证券交易所：4813）的全资子公司。
媒体联系
For press inquiries, analyst briefings, or media materials, please 联系我们团队 or email pr@ipinfusion.com.
前瞻性陈述
本新闻稿可能包含有关 IP Infusion 产品、技术和计划的前瞻性陈述。前瞻性陈述基于发布之日可获得的信息，涉及风险和不确定性，实际结果可能存在差异。产品计划、功能、发布时间和供应情况可能随时变更，恕不另行通知，且不构成任何承诺、保证或法律义务。IP Infusion 不承担更新任何前瞻性陈述的义务。